Summary. The 
direct effects on the testis? There is evidence to support the latter possibility since in the rat at least, LHRH agonists may exert both stimulatory and inhibitory effects directly on the Leydig cells (Sharpe, Doogan & Cooper, 1983a;  Sharpe, 1984) , the nature of the effect depending on the duration of exposure to the LHRH agonist and the degree of concomitant stimulation with LH (Sharpe, Doogan & Cooper, 1983b Rabin, Linde, Doelle & Alexander, 1981) , monkeys (Akhtar, Marshall, Wickings & Nieschlag, 1983; Akhtar, Wickings & Nieschlag, 1984) and the dog (Tremblay & Belanger, 1984; Vickery et ai, 1984) , suppression of sperm output can be achieved by peripheral administration of LHRH agonists, whilst in the rat only a partial reduction in sperm output occurs (Heber & Swerdloff, 1981) and fertility is often maintained (Vickery et ai, 1983) . Suppression of spermatogenesis by LHRH agonists is commonly considered to be secondary to impairment of Leydig cell steroidogenesis and testosterone secretion which occurs both in intact (Rivier, Rivier & Vale, 1979; Labrie et al., 1980a, b; Wang et al., 1983) and in hypophysectomized rats (Hsueh & Erickson, 1979; Bambino, Schreiber & Hsueh, 1980; Wang et al., 1983) . Despite impairment of steroidogenesis, the morphology of the Leydig cells has been reported to be either unchanged from normal (Labrie et al., , 1980b Pelletier et al, 1978 Pelletier et al, , 1980  Lefebvre, Belanger, Pelletier & Labrie, 1984) , atrophie (Rivier et al., 1979; Rajfer, Swerdloff & Heber, 1984) or hyperplastic (Vickery et al., 1983) . However, the degree of histological preservation of the testes in these studies was not of sufficient quality to evaluate these conclusions. Little information is available on the changes in testicular morphology which precede the reduction in sperm output and, as yet, no study has provided a clear indication of the morphological consequences of the direct actions of LHRH agonists on the testis. The aim of the present study was therefore to clarify some of the above points by examining changes in testicular structure, with particular attention to the Leydig cells, in hypophysectomized adult rats treated for 12-14 days with a low or high dose of LH, an LHRH agonist or the two hormones in combination. The morphological and morphometric data obtained were related to functional assessment of the Leydig cells in vitro and in vivo.
Materials and Methods
Animals and treatments. Sprague-Dawley rats hypophysectomized at 52 days of age were obtained from Charles River (U.K.) Ltd, Margate, Kent, U.K. and treatment begun 5-6 days postopera ti vely. Rats were maintained under standard conditions except that glucose (2-5 mg/ml) was added to the drinking water. Groups of 8 rats were then treated once daily at 09:00-10:00 h (subcutaneous injection) for 12 or 14 days with one of the following:
(1) 0-5 ml vehicle, consisting of 0-9% (w/v) NaCl, 2-5 mg gelatin/ml (Sigma, Poole, U.K.) and 2-5 mg bovine serum albumin/ml (BSA, fraction V; Sigma);
(2) 100 ng LHRH agonist [(D-Ser-r-bu6,des-Gly-NH210) LHRH ethylamide; Hoechst, A.G., F.R.G] in 0-5 ml vehicle; (3) 2 µg NIAMDD ovine LH-S24 in 0-5 ml vehicle; (4) 20 µg ovine LH-S24 in 0-5 ml vehicle; (5) 2 µg ovine LH-S24 + 100 ng LHRH agonist in 0-5 ml vehicle; (6) 20 µg ovine LH-S24 + 100 ng LHRH agonist in 0-5 ml vehicle. (Weibel, 1979) (Sharpe & Fraser, 1983) . The isolated cells were suspended in Medium 199, to which was added Earle's salts, NaHC03 (0-22%), lglutamine (2 mM; Flow Labs, Irvine, U.K.), transferrin (5 µg/ml; Sigma), insulin (10 µg/ml; Sigma), ceruloplasmin (1 U/ml; Sigma), penicillin (100 i.u./ml; Flow Labs), streptomycin (100µg/ml; Flow Labs), fungizone (2-5 µg/ml; Flow Labs) and BSA (0-5 mg/ml; Sigma). For (Sharpe & Fraser, 1983) . Testosterone production by the isolated cells has been expressed in ng/106 3ß-HSD-positive cells.
Measurement of testosterone. Testosterone concentrations in serum were measured by radio¬ immunoassay after extraction with 10 volumes of hexane:diethyl ether (4:1, v/v) as described and validated by Corker & Davidson (1978) . Assay of Leydig cell incubation media before and after extraction, as described above, gave comparable testosterone values (P > 0-2 by Student's t test; = 48), and unextracted diluted incubation media gave displacement curves parallel to the testosterone standard (P > 0-2 in a test of non-parallelism using 2-factor analysis of variance with replication). Incubation media were therefore assayed directly after appropriate dilution (between 1/20 and 1/500), and the limit of detection of the assay was 5 pg testosterone/sample. All samples of incubation medium or serum were assayed together in a single assay and the intra-assay coefficient of variation was <5%.
Statistical analysis. For the functional studies, results were analysed using 2-factor analysis of variance (with replication) and Student's t test. For morphometric studies, the effects of hormone treatment compared to saline treatment of hypophysectomized rats were analysed using Duncan's new multiple range test. Comparison between values for the normal testis and saline-treated hypophysectomized rats was made using two-tailed Student's t tests.
Results

Gross morphology
After perfusion fixation the mean + s.d. volume of testes from saline-treated hypophy¬ sectomized rats (0-442 + 0027 cm3) was significantly smaller ( < 005) than that of testes from normal intact rats (1-248 + 005 cm3). Amongst the groups of hormone-treated hypophysectomized rats, testes from rats treated with 2 µg LH (0-741 ± 0-081 cm3) were significantly (P < 001) larger than those of saline-treated rats, whilst testes from rats treated with 20 µg LH + LHRH agonist (0-281 ± 0-28cm3) were significantly (P < 005) smaller than those from saline-treated rats. No significant differences were noted for other hormone treatments (see Fig. 11 ). Treatment with 20 ßg LH. The cross-sectional area of all seminiferous tubules was markedly reduced compared to the treatment groups described above and different degrees of spermatogenic disruption had occurred ranging from severe to very severe damage to the seminiferous epithelium (Fig. 4) (Fig. 9) .
Morphometric analysis
The percentage of testis volume (volumetric density) occupied by Leydig cells, the interstitial space, other interstitial cells and the total interstitial compartment was significantly increased ( < 0 5-0 01) when the effects of 20 µg LH and 2 or 20 µg LH + LHRH agonist treatment were compared to those in saline-treated hypophysectomized rats (Fig. 10) . No significant differences were noted for the volumetric density of vascular lumina for any hormone treatment. Treatment with LHRH agonist or 2 µg LH did not significantly change the above parameters compared to saline treatment, except for the volumetric density of other interstitial cells which was significantly less (P < 0-01) after 2 µg treatment. When volumetric density data were converted to absolute volumes per whole testis, total Leydig cell volume was significantly increased (P < 005-0001) when treatment with 2 or 20 µg LH and 2 or 20 µg LH + LHRH agonist was compared to salinetreated rats (Fig. 11) (Fig. 12) . At 2 h after injection of 2 µg LH there was a significant (P < 0001) increase in testosterone concentrations on Days 1,3 and 7 of treatment but on Day 13 no significant increase occurred. In contrast, injection of 20 µg LH resulted in a significant (P < 0001) and relatively constant increase in serum testosterone levels at all of the sampling times (Fig. 12) . Injection of 100 ng LHRH agonist together with either of the doses of LH, had no significant effect on testosterone values on Day 1, but thereafter grossly attenuated the LH-stimulated increase in testosterone concentrations (P < 005 to < 0001), an effect that became progressively more marked with time (Fig. 12) .
Testosterone production by isolated Leydig cells Leydig cells isolated from the testes of vehicle-injected rats produced low amounts of testo¬ sterone basally, but responded to addition of LHRH agonist or hCG by increasing testosterone production 7-and 47-fold, respectively (Fig. 13) . Leydig cells isolated from the testes of rats treated with LHRH agonist alone showed an 85% reduction in basal testosterone production, when com¬ pared with cells from control rats, and whereas there was still a significant ( < 0001) response to LHRH agonist (3-fold) or hCG (43-fold), the levels of testosterone achieved were only 6% and 14%, respectively, of the comparable control values. Compared with controls, treatment of rats with 2 or 20µg LH caused major (P < 0001) increases in basal testosterone production and in responsiveness of the Leydig cells to LHRH agonist or hCG; the last two values were also significantly higher (P < 0001) for rats treated with 20 as opposed to 2 µg LH (Fig. 13) .
Treatment of rats with LH -f-LHRH agonist completely blocked (P < 0001) the stimulatory effects of the LH treatment and lowered the responsiveness of Leydig cells to LHRH agonist or hCG, to levels below that of cells from control rats (P < 0001; Fig. 13 (Rivier et al., 1979; Labrie et al., 1980b; Pelletier et ai, 1980) (Hsueh & Erickson, 1979; Bambino et al., 1980; Wang et ai, 1983) . Since LHRH agonists act directly upon Leydig cells (Sharpe et ai, 1983b) (Rivier et al., 1979; Pelletier et al., 1980) whereas in the absence of the pituitary, andro¬ gens plus LHRH agonists support qualitatively normal spermatogenesis (Rivier et al., 1979 (Rivier et al., 1979; Labrie et al., 1980a, b; Pelletier et ai, 1980; Vickery et ai, 1983; Lefebvre et al., 1984) . The central role played by LH in initiating and sustaining variable spermatogenic disruption is supported by other studies in which hCG + PMSG given to intact adult rats for 1-2 weeks caused degeneration of the seminiferous epithelium (Rivier et ai, 1979 (Christensen & Peacock, 1980) . While the present data do not provide a full explanation for the anti-spermatogenic effects of the treatment regimens, the results suggest that LH alone or in combination with LHRH agonist can focally inhibit spermatogenesis and, in certain seminiferous tubule areas, destroy all the cells of the seminiferous epithelium whereas the nearby Leydig cells undergo striking hyperplasia. The deleterious effects upon the seminiferous epithelium cannot be attributed solely to a lack of testosterone, and as they only occur in the presence of LH it is possible that some other LHregulated Leydig cell factor(s) is involved but their identity and mode of action remain unknown. The histological data suggest that the patchy disruption of the seminiferous tubules represents some stage-dependent sensitivity of the spermatogenic cycle to the factors which mediate these changes. Disappearance of Sertoli cells and germ cells and their replacement with dense aggre¬ gations of extracellular material has also been reported in LHRH agonist treated intact rats (Vickery et al., 1983) but tubules with normal seminiferous epithelia were also seen in the same testis. It is therefore likely that the focal degeneration of seminiferous tubules represents a very localized toxicological effect from which a proportion of seminiferous tubules fail to recover their spermatogenic function (Labrie et ai, 1980b; Pelletier et ai, 1980; Lefebvre et al, 1984) .
